Related Experiment Video
Updated: Sep 8, 2025
07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
43.8K
Marijuana and endothelial dysfunction: new mechanism and therapy
Xiaojun Feng1, Suowen Xu1, Jianping Weng1
1Department of Endocrinology, Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Clinical Research Hospital of Chinese Academy of Sciences (Hefei), University of Science and Technology of China, Hefei, Anhui, 230001, China.
Trends in Molecular Medicine
|June 14, 2022
Summary
Soy isoflavone genistein may treat cardiovascular issues caused by marijuana. This compound blocks the effects of delta-9-THC on blood vessels, offering a potential therapy for cannabis-related heart problems.
Area of Science:
- Cardiovascular Science
- Pharmacology
- Endocrinology
Background:
- Cannabis use is linked to cardiovascular side effects.
- The mechanisms underlying these effects and potential treatments are not well understood.
Purpose of the Study:
- To investigate the cardiovascular effects of delta-9-tetrahydrocannabinol (Δ9-THC).
- To identify potential therapeutic agents for mitigating cannabis-induced cardiovascular damage.
Main Methods:
- The study utilized a mouse model to examine the effects of Δ9-THC.
- Researchers investigated the interaction between genistein and cannabinoid receptor 1 (CB1).
- Endothelial function and atherosclerosis markers were assessed.
Main Results:
- Genistein was found to directly antagonize peripheral cannabinoid receptor 1.
- Genistein attenuated Δ9-THC-induced endothelial dysfunction.
- Genistein reduced Δ9-THC-induced atherosclerosis progression.
Conclusions:
- Soy isoflavone genistein demonstrates therapeutic potential for cardiovascular side effects associated with cannabis.
- Genistein's mechanism involves direct antagonism of peripheral CB1 receptors.
- This finding opens avenues for managing cannabis-related cardiovascular risks.
More Related Videos
Related Concept Videos
01:26Coronary Artery Disease II: Pathophysiology
33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
223
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
223
01:30Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
01:28Nitric Oxide Signaling Pathway
5.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.2K
01:24Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
01:29Hypertension II: Pathophysiology
73
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
73